| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.33B | 13.42B | 11.43B | 9.90B | 10.05B | 10.93B |
| Gross Profit | 6.55B | 7.61B | 5.69B | 4.32B | 4.56B | 6.19B |
| EBITDA | 7.21B | 8.02B | 6.54B | 5.12B | 5.38B | 6.86B |
| Net Income | 3.82B | 4.33B | 3.38B | 2.43B | 2.64B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 20.33B | 21.38B | 18.71B | 16.73B | 17.28B | 18.30B |
| Cash, Cash Equivalents and Short-Term Investments | 4.53B | 4.91B | 3.50B | 1.75B | 2.28B | 3.49B |
| Total Debt | 7.43B | 7.33B | 7.00B | 7.03B | 7.10B | 7.46B |
| Total Liabilities | 9.81B | 10.28B | 9.48B | 9.24B | 9.13B | 10.09B |
| Stockholders Equity | 10.45B | 11.04B | 9.17B | 7.42B | 8.08B | 8.15B |
Cash Flow | ||||||
| Free Cash Flow | 3.48B | 0.00 | 3.39B | 2.56B | 1.85B | 3.40B |
| Operating Cash Flow | 4.62B | 0.00 | 4.42B | 3.57B | 2.80B | 4.29B |
| Investing Cash Flow | -1.40B | 0.00 | -673.30M | -1.40B | -666.80M | -972.90M |
| Financing Cash Flow | -1.83B | 0.00 | -1.65B | -3.10B | -3.01B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $97.56B | 44.58 | 11.98% | 1.25% | 2.83% | 3.39% | |
76 Outperform | $174.04B | 45.69 | 39.45% | 2.07% | 12.70% | 25.51% | |
74 Outperform | $198.16B | 19.71 | 21.38% | 3.55% | -7.86% | 14.17% | |
72 Outperform | $134.99B | 19.41 | 22.21% | 0.95% | 26.25% | ― | |
69 Neutral | $165.65B | 15.95 | 17.00% | 4.60% | -0.44% | -4.20% | |
68 Neutral | $73.06B | 29.40 | 6.88% | 10.04% | -8.49% | -41.69% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |